ImaRx Pharma regulatory update

ImaRx received four U.S. patents covering aspects of its ultrasound contrast agent technology.

Read the full 136 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE